Beacon Trust’s Regeneron Pharmaceuticals REGN Stock Holding History

Beacon Trust’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	$243K	Hold	650	–	–	0.04%	164
2016 Q4	$239K	Sell	650 -118	-15%	-$44.9K	0.04%	165
2016 Q3	$309K	Hold	768	–	–	0.05%	150
2016 Q2	$268K	Sell	768 -4	-0.5%	-$1.54K	0.05%	156
2016 Q1	$278K	Buy	772 +122	+19%	+$50.3K	0.05%	149
2015 Q4	$353K	Hold	650	–	–	0.06%	139
2015 Q3	$302K	Hold	650	–	–	0.05%	151
2015 Q2	$332K	Hold	650	–	–	0.05%	153
2015 Q1	$293K	Hold	650	–	–	0.04%	174
2014 Q4	$267K	Hold	650	–	–	0.04%	182
2014 Q3	$234K	Buy	+650	New	+$218K	0.04%	173

Other funds holding REGN

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Polen Capital Management Boca Raton, Florida $14.5B AUM 5.7% 1-Year Est. Return

Beacon Trust's REGN Position: Q1 2017 in Review

Beacon Trust held its Regeneron Pharmaceuticals (REGN) position steady in Q1 2017 at 650 shares worth $243K. The position accounts for 0.04% of the portfolio, ranked #164.

Beacon Trust first reported a position in REGN in Q3 2014 and has held it in 11 quarters since. The position peaked at $353K in Q4 2015. 578 funds tracked by Wall St. Rank hold REGN as of Q1 2017.

Beacon Trust held 650 shares of Regeneron Pharmaceuticals worth $243K as of Q1 2017.
Beacon Trust left its Regeneron Pharmaceuticals share count unchanged in Q1 2017.
Regeneron Pharmaceuticals made up 0.04% of Beacon Trust's portfolio in Q1 2017, its #164 holding.
Beacon Trust first reported a position in Regeneron Pharmaceuticals in Q3 2014 and has held it in 11 quarters since.
Beacon Trust's Regeneron Pharmaceuticals position peaked at $353K in Q4 2015.
578 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2017.

Based on Beacon Trust's 13F filing for Q1 2017, filed 9 May 2017.